Pharma Journalist - Leading Magazine for Pharmaceutical Professionals

<!DOCTYPE html>    <html lang="en-US">  <head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="pingback" href="http://pharmajournalist.com/xmlrpc.php"/> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' /> <style>img:is([sizes="auto" i], [sizes^="auto," i]) { contain-intrinsic-size: 3000px 1500px }</style>  <title>Pharma Journalist - Leading Magazine for Pharmaceutical Professionals</title> <meta name="description" content="Pharma Journalist provides latest news, articles, whitepapers, press releases, case studies, Interviews, projects, events to Pharma Industry Decision Makers" /> <link rel="canonical" href="https://www.pharmajournalist.com/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="website" /> <meta property="og:title" content="Pharma Journalist - Leading Magazine for Pharmaceutical Professionals" /> <meta property="og:description" content="Pharma Journalist provides latest news, articles, whitepapers, press releases, case studies, Interviews, projects, events to Pharma Industry Decision Makers" /> <meta property="og:url" content="https://www.pharmajournalist.com/" /> <meta property="og:site_name" content="Pharma Journalist" /> <meta property="article:modified_time" content="2025-03-17T14:12:24+00:00" /> <meta property="og:image" content="https://pharmajournalist.com/wp-content/uploads/2017/04/Logo-Final.png" /> <meta property="og:image:width" content="1200" /> <meta property="og:image:height" content="872" /> <meta property="og:image:type" content="image/png" /> <meta name="twitter:card" content="summary_large_image" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"WebPage","@id":"https://www.pharmajournalist.com/","url":"https://www.pharmajournalist.com/","name":"Pharma Journalist - Leading Magazine for Pharmaceutical Professionals","isPartOf":{"@id":"https://www.pharmajournalist.com/#website"},"primaryImageOfPage":{"@id":"https://www.pharmajournalist.com/#primaryimage"},"image":{"@id":"https://www.pharmajournalist.com/#primaryimage"},"thumbnailUrl":"https://pharmajournalist.com/wp-content/uploads/2017/04/Logo-Final.png","datePublished":"2017-04-13T07:14:58+00:00","dateModified":"2025-03-17T14:12:24+00:00","description":"Pharma Journalist provides latest news, articles, whitepapers, press releases, case studies, Interviews, projects, events to Pharma Industry Decision Makers","breadcrumb":{"@id":"https://www.pharmajournalist.com/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://www.pharmajournalist.com/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https://www.pharmajournalist.com/#primaryimage","url":"https://pharmajournalist.com/wp-content/uploads/2017/04/Logo-Final.png","contentUrl":"https://pharmajournalist.com/wp-content/uploads/2017/04/Logo-Final.png","width":1200,"height":872,"caption":"Pharma journalist"},{"@type":"BreadcrumbList","@id":"https://www.pharmajournalist.com/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"WebSite","@id":"https://www.pharmajournalist.com/#website","url":"https://www.pharmajournalist.com/","name":"Pharma Journalist","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://www.pharmajournalist.com/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}</script>  <link rel='dns-prefetch' href='//pharmajournalist.com' /> <link rel='dns-prefetch' href='//fonts.googleapis.com' /> <link rel="alternate" type="application/rss+xml" title="Pharma Journalist » Feed" href="http://www.pharmajournalist.com/feed/" /> <link rel="alternate" type="application/rss+xml" title="Pharma Journalist » Comments Feed" href="http://www.pharmajournalist.com/comments/feed/" /> <link rel="alternate" type="text/calendar" title="Pharma Journalist » iCal Feed" href="http://www.pharmajournalist.com/events/?ical=1" /> <script type="text/javascript"> /* <![CDATA[ */ window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/svg\/","svgExt":".svg","source":{"concatemoji":"http:\/\/pharmajournalist.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=6.7.2"}}; /*! This file is auto-generated */ !function(i,n){var o,s,e;function c(e){try{var t={supportTests:e,timestamp:(new Date).valueOf()};sessionStorage.setItem(o,JSON.stringify(t))}catch(e){}}function p(e,t,n){e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(t,0,0);var t=new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data),r=(e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(n,0,0),new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data));return t.every(function(e,t){return e===r[t]})}function u(e,t,n){switch(t){case"flag":return n(e,"\ud83c\udff3\ufe0f\u200d\u26a7\ufe0f","\ud83c\udff3\ufe0f\u200b\u26a7\ufe0f")?!1:!n(e,"\ud83c\uddfa\ud83c\uddf3","\ud83c\uddfa\u200b\ud83c\uddf3")&&!n(e,"\ud83c\udff4\udb40\udc67\udb40\udc62\udb40\udc65\udb40\udc6e\udb40\udc67\udb40\udc7f","\ud83c\udff4\u200b\udb40\udc67\u200b\udb40\udc62\u200b\udb40\udc65\u200b\udb40\udc6e\u200b\udb40\udc67\u200b\udb40\udc7f");case"emoji":return!n(e,"\ud83d\udc26\u200d\u2b1b","\ud83d\udc26\u200b\u2b1b")}return!1}function f(e,t,n){var r="undefined"!=typeof WorkerGlobalScope&&self instanceof WorkerGlobalScope?new OffscreenCanvas(300,150):i.createElement("canvas"),a=r.getContext("2d",{willReadFrequently:!0}),o=(a.textBaseline="top",a.font="600 32px Arial",{});return e.forEach(function(e){o[e]=t(a,e,n)}),o}function t(e){var t=i.createElement("script");t.src=e,t.defer=!0,i.head.appendChild(t)}"undefined"!=typeof Promise&&(o="wpEmojiSettingsSupports",s=["flag","emoji"],n.supports={everything:!0,everythingExceptFlag:!0},e=new Promise(function(e){i.addEventListener("DOMContentLoaded",e,{once:!0})}),new Promise(function(t){var n=function(){try{var e=JSON.parse(sessionStorage.getItem(o));if("object"==typeof e&&"number"==typeof e.timestamp&&(new Date).valueOf()<e.timestamp+604800&&"object"==typeof e.supportTests)return e.supportTests}catch(e){}return null}();if(!n){if("undefined"!=typeof Worker&&"undefined"!=typeof OffscreenCanvas&&"undefined"!=typeof URL&&URL.createObjectURL&&"undefined"!=typeof Blob)try{var e="postMessage("+f.toString()+"("+[JSON.stringify(s),u.toString(),p.toString()].join(",")+"));",r=new Blob([e],{type:"text/javascript"}),a=new Worker(URL.createObjectURL(r),{name:"wpTestEmojiSupports"});return void(a.onmessage=function(e){c(n=e.data),a.terminate(),t(n)})}catch(e){}c(n=f(s,u,p))}t(n)}).then(function(e){for(var t in e)n.supports[t]=e[t],n.supports.everything=n.supports.everything&&n.supports[t],"flag"!==t&&(n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&n.supports[t]);n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&!n.supports.flag,n.DOMReady=!1,n.readyCallback=function(){n.DOMReady=!0}}).then(function(){return e}).then(function(){var e;n.supports.everything||(n.readyCallback(),(e=n.source||{}).concatemoji?t(e.concatemoji):e.wpemoji&&e.twemoji&&(t(e.twemoji),t(e.wpemoji)))}))}((window,document),window._wpemojiSettings); /* ]]> */ </script> <style id='wp-emoji-styles-inline-css' type='text/css'> img.wp-smiley, img.emoji { display: inline !important; border: none !important; box-shadow: none !important; height: 1em !important; width: 1em !important; margin: 0 0.07em !important; vertical-align: -0.1em !important; background: none !important; padding: 0 !important; } </style> <link rel='stylesheet' id='wp-block-library-css' href='http://pharmajournalist.com/wp-includes/css/dist/block-library/style.min.css?ver=6.7.2' type='text/css' media='all' /> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css' type='text/css'> :root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} :root :where(.wp-block-pullquote){font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='cm_ouibounce_css-css' href='http://pharmajournalist.com/wp-content/plugins/cm-pop-up-banners/shared/assets/css/ouibounce.css?ver=1.7.8' type='text/css' media='all' /> <style id='cm_ouibounce_css-inline-css' type='text/css'> #ouibounce-modal .modal { width: 600px; height: 400px; padding: 10px; background-color: transparent; z-index: 20; position: relative; margin: auto; top: 0; right: 0; bottom: 0; left: 0; display: flex; overflow: visible; opacity: 1; max-width: 85%; max-height: 85%; border-radius: 4px; -webkit-animation: popin 1.0s;; -moz-animation: popin 1.0s;; -o-animation: popin 1.0s;; animation: popin 1.0s;; }#ouibounce-modal .underlay {background-color: rgba(0,0,0,0.5);}#ouibounce-modal .modal .modal-body * { max-width: 100%; max-height: 100%; }#ouibounce-modal .modal .modal-body *:not(iframe) { height: auto; }#ouibounce-modal .modal .modal-body iframe { display: flex; align-items: center; }#ouibounce-modal .modal.linked { cursor: pointer; }@media (max-width: 400px) {#ouibounce-modal .modal {width: auto; height: auto;} } </style> <link rel='stylesheet' id='cookie-notice-front-css' href='http://pharmajournalist.com/wp-content/plugins/cookie-notice/css/front.min.css?ver=2.5.5' type='text/css' media='all' /> <link rel='stylesheet' id='js_composer_front-css' href='http://pharmajournalist.com/wp-content/plugins/js_composer/assets/css/js_composer.min.css?ver=7.9' type='text/css' media='all' /> <link rel='stylesheet' id='better-framework-main-fonts-css' href='https://fonts.googleapis.com/css?family=Roboto:400,300,500,400italic,700&display=swap' type='text/css' media='all' /> <script type="text/javascript" src="http://pharmajournalist.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1" id="jquery-core-js"></script> <script type="text/javascript" src="http://pharmajournalist.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1" id="jquery-migrate-js"></script> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/cm-pop-up-banners/shared/assets/js/ouibounce.js?ver=1.7.8" id="cmpopfly-popup-core-js"></script> <script type="text/javascript" id="cmpopfly-popup-custom-js-extra"> /* <![CDATA[ */ var WidgetConf = {"closeTime":null}; /* ]]> */ </script> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/cm-pop-up-banners/shared/assets/js/popupCustom.js?ver=1.7.8" id="cmpopfly-popup-custom-js"></script> <script type="text/javascript" id="cmpopfly-popup-custom-js-after"> /* <![CDATA[ */ var popup_custom_data = {"content":"<div id=\"ouibounce-modal\" class=\"cm-popup-modal\">\n <div class=\"underlay\"><\/div>\n \n \n <div class=\"modal \">\n <div id=\"close_button\" class=\"popupflyin-close-button\"><\/div>\n <div class=\"modal-body popupflyin-clicks-area \"><p><a href='https:\/\/reg.cphi-china.cn\/en\/user\/register?utm_source=media&utm_medium=referral&utm_campaign=ensinoPJbanner' target='_blank' rel='noopener'><img class='size-full wp-image-40589 aligncenter' src='https:\/\/pharmajournalist.com\/wp-content\/uploads\/2025\/02\/CPHI25-600_400.png' alt='' width='608' height='408' \/><\/a><\/p><\/div>\n <\/div>\n <\/div>","showMethod":"always","resetTime":7,"secondsToShow":0,"minDeviceWidth":0,"maxDeviceWidth":0,"fireMethod":"pageload","ajaxClickUrl":"https:\/\/pharmajournalist.com\/wp-admin\/admin-ajax.php?action=cm_popupflyin_register_click","campaign_id":39842,"banner_id":"1 (460720725)","enableStatistics":false,"countingMethod":"one","soundMethod":"none","customSoundPath":"","standardSound":"http:\/\/pharmajournalist.com\/wp-content\/plugins\/cm-pop-up-banners\/shared\/assets\/media\/default_popup_sound.mp3","closeOnUnderlayClick":false,"inactivityTime":10,"showFixedNumberOfTimes":5}; /* ]]> */ </script> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/cm-pop-up-banners/shared/assets/js/scrollspy.js?ver=1.7.8" id="scrollspy-js"></script> <script type="text/javascript" id="cookie-notice-front-js-before"> /* <![CDATA[ */ var cnArgs = {"ajaxUrl":"https:\/\/pharmajournalist.com\/wp-admin\/admin-ajax.php","nonce":"23c07164b4","hideEffect":"fade","position":"top","onScroll":true,"onScrollOffset":150,"onClick":false,"cookieName":"cookie_notice_accepted","cookieTime":2592000,"cookieTimeRejected":2592000,"globalCookie":false,"redirection":false,"cache":false,"revokeCookies":false,"revokeCookiesOpt":"automatic"}; /* ]]> */ </script> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/cookie-notice/js/front.min.js?ver=2.5.5" id="cookie-notice-front-js"></script>   <script></script><link rel="https://api.w.org/" href="http://www.pharmajournalist.com/wp-json/" /><link rel="alternate" title="JSON" type="application/json" href="http://www.pharmajournalist.com/wp-json/wp/v2/pages/299" /><link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://pharmajournalist.com/xmlrpc.php?rsd" /> <meta name="generator" content="WordPress 6.7.2" /> <link rel='shortlink' href='http://www.pharmajournalist.com/' /> <link rel="alternate" title="oEmbed (JSON)" type="application/json+oembed" href="http://www.pharmajournalist.com/wp-json/oembed/1.0/embed?url=http%3A%2F%2Fwww.pharmajournalist.com%2F" /> <link rel="alternate" title="oEmbed (XML)" type="text/xml+oembed" href="http://www.pharmajournalist.com/wp-json/oembed/1.0/embed?url=http%3A%2F%2Fwww.pharmajournalist.com%2F&format=xml" /> <link rel="amphtml" href="http://www.pharmajournalist.com/amp/"/> <meta name="tec-api-version" content="v1"><meta name="tec-api-origin" content="http://www.pharmajournalist.com"><link rel="alternate" href="http://www.pharmajournalist.com/wp-json/tribe/events/v1/" /><link rel="apple-touch-icon" sizes="152x152" href="/wp-content/uploads/fbrfg/apple-touch-icon.png"> <link rel="icon" type="image/png" href="/wp-content/uploads/fbrfg/favicon-32x32.png" sizes="32x32"> <link rel="icon" type="image/png" href="/wp-content/uploads/fbrfg/favicon-16x16.png" sizes="16x16"> <link rel="manifest" href="/wp-content/uploads/fbrfg/manifest.json"> <link rel="mask-icon" href="/wp-content/uploads/fbrfg/safari-pinned-tab.svg" color="#5bbad5"> <link rel="shortcut icon" href="/wp-content/uploads/fbrfg/favicon.ico"> <meta name="msapplication-config" content="/wp-content/uploads/fbrfg/browserconfig.xml"> <meta name="theme-color" content="#ffffff"><meta name="generator" content="Powered by WPBakery Page Builder - drag and drop page builder for WordPress."/> <script type="application/ld+json">{ "@context": "http://schema.org/", "@type": "Organization", "@id": "#organization", "logo": { "@type": "ImageObject", "url": "http://www.pharmajournalist.com/wp-content/uploads/2018/02/Pharma-Journalist_logo.png" }, "url": "http://www.pharmajournalist.com/", "name": "Pharma Journalist", "description": "" }</script> <script type="application/ld+json">{ "@context": "http://schema.org/", "@type": "WebSite", "name": "Pharma Journalist", "alternateName": "", "url": "http://www.pharmajournalist.com/", "potentialAction": { "@type": "SearchAction", "target": "http://www.pharmajournalist.com/search/{search_term}", "query-input": "required name=search_term" } }</script> <link rel='stylesheet' id='bf-minifed-css-1' href='http://pharmajournalist.com/wp-content/bs-booster-cache/fc037430c52fd62a22bd0d1f65451f40.css' type='text/css' media='all' /> <link rel='stylesheet' id='7.11.0-1742562214' href='http://pharmajournalist.com/wp-content/bs-booster-cache/a8c33e204e60178551fc82cda9e9c2ee.css' type='text/css' media='all' /> <style> body,body.boxed{background-color:#ffffff} </style> <style type="text/css" data-type="vc_shortcodes-custom-css">.vc_custom_1510572616682{border-bottom-width: 1px !important;background-color: #ffffff !important;border-bottom-color: #ced9e1 !important;border-bottom-style: solid !important;}.vc_custom_1526378725487{background-color: #dbdbdb !important;}.vc_custom_1526380556886{background-color: #dbdbdb !important;}.vc_custom_1518295991983{margin-bottom: 0px !important;border-top-width: 1px !important;border-right-width: 1px !important;border-bottom-width: 0px !important;border-left-width: 1px !important;border-left-color: #d2dce3 !important;border-left-style: solid !important;border-right-color: #d2dce3 !important;border-right-style: solid !important;border-top-color: #d2dce3 !important;border-top-style: solid !important;border-bottom-color: #d2dce3 !important;border-bottom-style: solid !important;}.vc_custom_1526379515607{border-top-width: 0px !important;border-right-width: 1px !important;border-bottom-width: 1px !important;border-left-width: 1px !important;border-left-color: #d2dce3 !important;border-left-style: solid !important;border-right-color: #d2dce3 !important;border-right-style: solid !important;border-top-color: #d2dce3 !important;border-top-style: solid !important;border-bottom-color: #d2dce3 !important;border-bottom-style: solid !important;}.vc_custom_1526381240397{background-color: #dbdbdb !important;}.vc_custom_1526387820018{background-color: #dbdbdb !important;}.vc_custom_1526387576649{background-color: #dbdbdb !important;}.vc_custom_1526386024033{background-color: #dbdbdb !important;}</style><noscript><style> .wpb_animate_when_almost_visible { opacity: 1; }</style></noscript> </head> <body class="home page-template-default page page-id-299 cookies-not-set tribe-no-js page-template-publisher bs-theme bs-publisher bs-publisher-top-news active-light-box ltr close-rh page-layout-3-col page-layout-3-col-0 page-layout-no-sidebar full-width active-sticky-sidebar main-menu-full-width bs-hide-ha wpb-js-composer js-comp-ver-7.9 vc_responsive bs-ll-a" dir="ltr"> <div class="npbh npbh-before-header npbh-pubadban npbh-show-desktop npbh-show-tablet-portrait npbh-show-tablet-landscape npbh-show-phone npbh-loc-header_before npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40646-1178186446" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40646" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/esarrv" target="_blank" ><img class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/03/mRNA-Based-Therapeutics-Summit-728x90-1.png" alt="mRNA-Based Therapeutics Summit Leaderboard" /></a></div></div> <div class="main-wrap content-main-wrap"> <header id="header" class="site-header header-style-2 full-width" itemscope="itemscope" itemtype="http://schema.org/WPHeader"> <section class="topbar topbar-style-1 hidden-xs hidden-xs"> <div class="content-wrap"> <div class="container"> <div class="topbar-inner clearfix"> <div class="section-menu"> <div id="menu-top" class="menu top-menu-wrapper" role="navigation" itemscope="itemscope" itemtype="http://schema.org/SiteNavigationElement"> <nav class="top-menu-container"> <ul id="top-navigation" class="top-menu menu clearfix bsm-pure"> <li id="topbar-date" class="menu-item menu-item-date"> <span class="topbar-date">Tuesday, March 25, 2025</span> </li> <li id="menu-item-461" class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-461"><a href="http://www.pharmajournalist.com/about/">About</a></li> <li id="menu-item-462" class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-462"><a href="http://www.pharmajournalist.com/advertise/">Advertise</a></li> <li id="menu-item-464" class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-464"><a href="http://www.pharmajournalist.com/subscribe/">Subscribe</a></li> <li id="menu-item-463" class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-463"><a href="http://www.pharmajournalist.com/contact/">Contact</a></li> </ul> </nav> </div> </div> </div> </div> </div> </section> <div class="header-inner"> <div class="content-wrap"> <div class="container"> <div class="row"> <div class="row-height"> <div class="logo-col col-xs-4"> <div class="col-inside"> <div id="site-branding" class="site-branding"> <h1 id="site-title" class="logo h1 img-logo"> <a href="http://www.pharmajournalist.com/" itemprop="url" rel="home"> <img id="site-logo" src="http://www.pharmajournalist.com/wp-content/uploads/2018/02/Pharma-Journalist_logo.png" alt="Pharma Journalist" /> <span class="site-title">Pharma Journalist - </span> </a> </h1> </div> </div> </div> <div class="sidebar-col col-xs-8"> <div class="col-inside"> <aside id="sidebar" class="sidebar" role="complementary" itemscope="itemscope" itemtype="http://schema.org/WPSideBar"> <div class="npbh npbh-pubadban npbh-show-desktop npbh-show-tablet-portrait npbh-show-tablet-landscape npbh-show-phone npbh-loc-header_aside_logo npbh-align-left npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40595-1371601617" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40595" data-type="image"><a itemprop="url" class="npbh-link" href="https://reg.cphi-china.cn/en/user/register?utm_source=media&utm_medium=referral&utm_campaign=ensinoPJbanner" target="_blank" ><img class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/CPHI25-728_90.png" alt="CPHI & PMEC China 2025 Leaderboard" /></a></div></div> </aside> </div> </div> </div> </div> </div> </div> </div> <div id="menu-main" class="menu main-menu-wrapper" role="navigation" itemscope="itemscope" itemtype="http://schema.org/SiteNavigationElement"> <div class="main-menu-inner"> <div class="content-wrap"> <div class="container"> <nav class="main-menu-container"> <ul id="main-navigation" class="main-menu menu bsm-pure clearfix"> <li id="menu-item-138" class="menu-have-icon menu-icon-type-fontawesome menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-title-hide better-anim-fade menu-item-138"><a href="http://www.pharmajournalist.com" aria-current="page"><i class="bf-icon fa fa-home"></i><span class="hidden">Home</span></a></li> <li id="menu-item-139" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-3 better-anim-fade menu-item-139"><a href="http://www.pharmajournalist.com/category/pharma-news/">News</a></li> <li id="menu-item-124" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-24 better-anim-fade menu-item-124"><a href="http://www.pharmajournalist.com/category/drug-research/">Drug Research</a></li> <li id="menu-item-121" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-25 better-anim-fade menu-item-121"><a href="http://www.pharmajournalist.com/category/clinical-trials/">Clinical Trials</a></li> <li id="menu-item-129" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-26 better-anim-fade menu-item-129"><a href="http://www.pharmajournalist.com/category/manufacturing/">Manufacturing</a></li> <li id="menu-item-127" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-27 better-anim-fade menu-item-127"><a href="http://www.pharmajournalist.com/category/information-technology/">Information Technology</a></li> <li id="menu-item-131" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-28 better-anim-fade menu-item-131"><a href="http://www.pharmajournalist.com/category/packaging-labeling/">Packaging & Labeling</a></li> <li id="menu-item-1453" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-30 better-anim-fade menu-item-1453"><a href="http://www.pharmajournalist.com/category/diseases/">Diseases</a></li> <li id="menu-item-135" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-term-33 better-anim-fade menu-item-135"><a href="http://www.pharmajournalist.com/category/resources/">Resources</a> <ul class="sub-menu"> <li id="menu-item-119" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-34 better-anim-fade menu-item-119"><a href="http://www.pharmajournalist.com/category/articles/">Articles</a></li> <li id="menu-item-133" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-37 better-anim-fade menu-item-133"><a href="http://www.pharmajournalist.com/category/projects/">Projects</a></li> <li id="menu-item-120" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-40 better-anim-fade menu-item-120"><a href="http://www.pharmajournalist.com/category/case-studies/">Case Studies</a></li> <li id="menu-item-126" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-38 better-anim-fade menu-item-126"><a href="http://www.pharmajournalist.com/category/industry-reports/">Industry Reports</a></li> <li id="menu-item-128" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-36 better-anim-fade menu-item-128"><a href="http://www.pharmajournalist.com/category/interviews/">Interviews</a></li> <li id="menu-item-137" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-39 better-anim-fade menu-item-137"><a href="http://www.pharmajournalist.com/category/white-papers/">White Papers</a></li> </ul> </li> <li id="menu-item-9761" class="menu-item menu-item-type-custom menu-item-object-custom better-anim-fade menu-item-9761"><a href="http://www.pharmajournalist.com/events">Events</a></li> <li id="menu-item-132" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-term-35 better-anim-fade menu-item-132"><a href="http://www.pharmajournalist.com/category/press-releases/">Press Releases</a></li> </ul> </nav> </div> </div> </div> </div> </header> <div class="rh-header clearfix dark deferred-block-exclude"> <div class="rh-container clearfix"> <div class="menu-container close"> <span class="menu-handler"><span class="lines"></span></span> </div> <div class="logo-container rh-img-logo"> <a href="http://www.pharmajournalist.com/" itemprop="url" rel="home"> <img src="http://www.pharmajournalist.com/wp-content/uploads/2018/02/Pharma-Journalist_logo.png" alt="Pharma Journalist" /> </a> </div> </div> </div> <main id="content" class="content-container"> <div class="layout-3-col layout-3-col-0"> <div class="main-section"> <div class="content-column"> <div class="single-container bs-vc-content"> <div class="wpb-content-wrapper"><div data-vc-full-width="true" data-vc-full-width-init="false" class="row vc_row wpb_row vc_row-fluid vc_custom_1510572616682 vc_row-has-fill"><div class="bs-vc-wrapper"><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-12"><div class="bs-vc-wrapper wpb_wrapper"></p> <div id="newsticker-1216348189" class="better-newsticker " data-speed="15000"> <p class="heading ">Trending</p> <ul class="news-list"> <li> <a class="limit-line" href="http://www.pharmajournalist.com/fda-approves-alnylams-amvuttra-for-attr-cm/"> FDA Approves Alnylam’s AMVUTTRA for ATTR-CM </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/servier-and-black-diamond-strike-licensing-deal-for-bdtx-4933/"> Servier and Black Diamond Strike Licensing Deal for BDTX-4933 </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/menarini-partners-with-visualdx-to-identify-bpdcn/"> Menarini Partners with VisualDx to Identify BPDCN </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/"> Novartis Gains FDA Approval for Fabhalta in C3G </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/altesa-biosciences-announces-clearance-of-investigational-new-drug-ind-application-for-vapendavir/"> Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/oxford-biotherapeutics-partners-with-roche-on-cancer-targets/"> Oxford BioTherapeutics Partners with Roche on Cancer Targets </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/opko-health-and-entera-bio-partner-to-advance-oral-glp-1-tablet-for-obesity-and-metabolic-disorders/"> OPKO Health and Entera Bio Partner to Advance Oral GLP-1 Tablet for Obesity and Metabolic Disorders </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/salipro-biotech-and-boehringer-ingelheim-strike-research-and-license-deal-to-boost-pipeline-programs/"> Salipro Biotech and Boehringer Ingelheim Strike Research and License Deal to Boost Pipeline Programs </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/astrazeneca-signs-license-deal-with-alteogen-for-subcutaneous-oncology-formulations/"> AstraZeneca Signs License Deal with Alteogen for Subcutaneous Oncology Formulations </a> </li> <li> <a class="limit-line" href="http://www.pharmajournalist.com/astrazeneca-to-acquire-esobiotec-to-boost-cell-therapy-goals/"> AstraZeneca to Acquire EsoBiotec to Boost Cell Therapy Goals </a> </li> </ul> </div> <p></div></div></div></div><div class="vc_row-full-width vc_clearfix"></div><div class="row vc_row wpb_row vc_row-fluid"><div class="bs-vc-wrapper"><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-3 vc_col-lg-3 vc_hidden-md vc_hidden-sm vc_hidden-xs bs-vc-sidebar-column"><div class="bs-vc-wrapper wpb_wrapper"><div class="bscb-43165 vc_custom_1526378725487 have_bg bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-35"> <a href="http://www.pharmajournalist.com/category/press-releases/" class="main-link"> <span class="h-text main-term-35"> Press Releases </span> </a> </p> <style> .bscb-43165.bscb-43165 .section-heading.sh-t1 .h-text,.bscb-43165.bscb-43165 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-43165.bscb-43165 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-43165.bscb-43165 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-43165.bscb-43165 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-43165.bscb-43165 .section-heading.sh-t7 > a > .h-text,.bscb-43165.bscb-43165 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-43165.bscb-43165 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <div class="post-40680 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="The Tumour Models Summit Hits Sweden!" data-src="https://pharmajournalist.com/wp-content/uploads/2025/03/Tumour-Models-Nordics-Infographic-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2025\/03\/","sizes":{"86":"Tumour-Models-Nordics-Infographic-86x64.jpg","210":"Tumour-Models-Nordics-Infographic-210x136.jpg","800":"Tumour-Models-Nordics-Infographic.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/the-tumour-models-summit-hits-sweden/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/the-tumour-models-summit-hits-sweden/" class="post-url post-title"> The Tumour Models Summit Hits Sweden! </a> </p> </div> </div > <div class="post-40102 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="5th Genome Editing Therapeutics Summit is only 3 weeks away!" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/47290-4-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"47290-4-86x64.png","210":"47290-4-210x136.png","800":"47290-4.png"}}" class="img-holder" href="http://www.pharmajournalist.com/5th-genome-editing-therapeutics-summit-is-only-3-weeks-away/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/5th-genome-editing-therapeutics-summit-is-only-3-weeks-away/" class="post-url post-title"> 5th Genome Editing Therapeutics Summit is only 3 weeks… </a> </p> </div> </div > <div class="post-40062 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/11th-World-ADC-Awards-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"11th-World-ADC-Awards-86x64.png","210":"11th-World-ADC-Awards-210x136.png","500":"11th-World-ADC-Awards.png"}}" class="img-holder" href="http://www.pharmajournalist.com/celebrating-more-than-a-decade-of-excellence-at-the-world-adc-awards-winners-announcement/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/celebrating-more-than-a-decade-of-excellence-at-the-world-adc-awards-winners-announcement/" class="post-url post-title"> Celebrating More than a Decade of Excellence at the World… </a> </p> </div> </div > <div class="post-40023 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Final Week to Save $350: Accelerate Your Gene Editing Program" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/47290-4-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"47290-4-86x64.png","210":"47290-4-210x136.png","800":"47290-4.png"}}" class="img-holder" href="http://www.pharmajournalist.com/final-week-to-save-350-accelerate-your-gene-editing-program/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/final-week-to-save-350-accelerate-your-gene-editing-program/" class="post-url post-title"> Final Week to Save $350: Accelerate Your Gene Editing… </a> </p> </div> </div > <div class="post-40020 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="An Interview with Jeffrey Cehelsky, Intellia Therapeutics" data-src="https://pharmajournalist.com/wp-content/uploads/2024/09/48775-Pharma-J-Banner-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/09\/","sizes":{"86":"48775-Pharma-J-Banner-86x64.png","210":"48775-Pharma-J-Banner-210x136.png","300":"48775-Pharma-J-Banner.png"}}" class="img-holder" href="http://www.pharmajournalist.com/an-interview-with-jeffrey-cehelsky-intellia-therapeutics/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/an-interview-with-jeffrey-cehelsky-intellia-therapeutics/" class="post-url post-title"> An Interview with Jeffrey Cehelsky, Intellia Therapeutics </a> </p> </div> </div > </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40645-1783246765" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40645" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/esarrv" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/03/mRNA-Based-Therapeutics-Summit-300x250-1.png" alt="mRNA-Based Therapeutics Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40529-948220968" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40529" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/28pvo1" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/PharmaJournalist_3rdGTxPotencyAssay.png" alt="3rd Gene Therapy Potency Assay Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40351-310222121" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40351" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/adqtg1" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/01/56868-Pharmajournalist.jpg" alt="Treg-Directed Therapies Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40608-682812356" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40608" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/qdc9zo" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/Tumour-Models-Nordics-Banner-Pharma-Journalist.gif" alt="Tumour Models Summit Nordics" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40552-1924534162" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40552" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/eynnsw" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/54221-ADC-Payload-Pharma-Journalist.png" alt="2nd ADC Payload Summit" /></a></div></div> <div class="bscb-20843 vc_custom_1526380556886 have_bg bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-39"> <a href="http://www.pharmajournalist.com/category/white-papers/" class="main-link"> <span class="h-text main-term-39"> Whitepapers </span> </a> </p> <style> .bscb-20843.bscb-20843 .section-heading.sh-t1 .h-text,.bscb-20843.bscb-20843 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-20843.bscb-20843 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-20843.bscb-20843 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-20843.bscb-20843 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-20843.bscb-20843 .section-heading.sh-t7 > a > .h-text,.bscb-20843.bscb-20843 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-20843.bscb-20843 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <div class="post-37858 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-34"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Extractables and Leachables Europe 2023 medical devices focus" data-src="https://pharmajournalist.com/wp-content/uploads/2023/09/Pharma-Journalist-Extractables-Leachables-Europe-2023-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2023\/09\/","sizes":{"86":"Pharma-Journalist-Extractables-Leachables-Europe-2023-86x64.jpg","210":"Pharma-Journalist-Extractables-Leachables-Europe-2023-210x136.jpg","300":"Pharma-Journalist-Extractables-Leachables-Europe-2023.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/extractables-and-leachables-europe-2023-medical-devices-focus/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/extractables-and-leachables-europe-2023-medical-devices-focus/" class="post-url post-title"> Extractables and Leachables Europe 2023 medical devices… </a> </p> </div> </div > <div class="post-18122 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-39"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Ebook: DATAx Guide to How Machine Learning Will Transform The Pharmaceutical Supply Chain" data-src="https://pharmajournalist.com/wp-content/uploads/2018/10/DataX-Logo-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/10\/","sizes":{"86":"DataX-Logo-86x64.jpg","210":"DataX-Logo-210x136.jpg","400":"DataX-Logo.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/ebook-datax-guide-to-how-machine-learning-will-transform-the-pharmaceutical-supply-chain/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/ebook-datax-guide-to-how-machine-learning-will-transform-the-pharmaceutical-supply-chain/" class="post-url post-title"> Ebook: DATAx Guide to How Machine Learning Will Transform… </a> </p> </div> </div > <div class="post-2016 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-25"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="TrialScope Launches Second Global Clinical Trial Disclosure Maturity" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"86":"clinical-trials-86x64.png","210":"clinical-trials-210x136.png","995":"clinical-trials.png"}}" class="img-holder" href="http://www.pharmajournalist.com/trialscope-launches-second-global-clinical-trial-disclosure-maturity/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/trialscope-launches-second-global-clinical-trial-disclosure-maturity/" class="post-url post-title"> TrialScope Launches Second Global Clinical Trial Disclosure… </a> </p> </div> </div > <div class="post-1071 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-39"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="New sPCMA White Paper: PBM Specialty Pharmacies Improve Patient Outcomes and Reduce Costs" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/pcma-logo-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"86":"pcma-logo-86x64.jpg","210":"pcma-logo-210x136.jpg","927":"pcma-logo.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/new-spcma-white-paper-pbm-specialty-pharmacies-improve-patient-outcomes-reduce-costs/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/new-spcma-white-paper-pbm-specialty-pharmacies-improve-patient-outcomes-reduce-costs/" class="post-url post-title"> New sPCMA White Paper: PBM Specialty Pharmacies Improve… </a> </p> </div> </div > <div class="post-1564 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-39"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Top 5 Reasons to Outsource Your Site Payments Process" data-src="https://pharmajournalist.com/wp-content/uploads/2017/05/drugdev-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/05\/","sizes":{"86":"drugdev-86x64.png","210":"drugdev-210x136.png","300":"drugdev.png"}}" class="img-holder" href="http://www.pharmajournalist.com/top-5-reasons-outsource-site-payments-process/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/top-5-reasons-outsource-site-payments-process/" class="post-url post-title"> Top 5 Reasons to Outsource Your Site Payments Process </a> </p> </div> </div > </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40245-1716974639" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40245" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/8u0s3n" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/12/Biophysics-for-Drug-Discovery.png" alt="Biophysics for Drug Discovery Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40524-1776042572" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40524" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/lemzh2" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/Pharmaj-56674-1-1.png" alt="Circular & Self-Amplifying RNA Therapeutics Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-39885-1817744074" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="39885" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/fqxr57" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/10/10th-Innate-Killer-PJ-Banner.jpg" alt="10th Annual Innate Killer Summit" /></a></div></div> <p></div></div><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-8 vc_col-lg-6 vc_col-md-8"><div class="bs-vc-wrapper wpb_wrapper"><div class="vc_custom_1518295991983 bs-listing bs-listing-slider-1 bs-listing-single-tab"> <div class="bs-shortcode bs-slider bs-slider-1 clearfix "> <div class="better-slider" id="slider-64760790" data-slideshowSpeed="7000" data-animation="fade" data-controlNav="1" data-animationSpeed="600"> <ul class="slides"> <li class="slide bs-slider-item bs-slider-1-item main-term-3 has-post-thumbnail"> <div class="item-content"> <a class="img-cont" href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/" style="background-image: url('https://pharmajournalist.com/wp-content/uploads/2017/10/novartis-1130x580.jpg')"></a> <div class="content-container"> <h3 class="title"> <a class="post-url post-title" href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/"> Novartis Gains FDA Approval for Fabhalta in C3G </a> </h3> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-20T23:59:48+05:30">Mar 20, 2025</time></span> </div> </div> </div> </li> <li class="slide bs-slider-item bs-slider-1-item main-term-3 has-post-thumbnail"> <div class="item-content"> <a class="img-cont" href="http://www.pharmajournalist.com/oxford-biotherapeutics-partners-with-roche-on-cancer-targets/" style="background-image: url('https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg')"></a> <div class="content-container"> <h3 class="title"> <a class="post-url post-title" href="http://www.pharmajournalist.com/oxford-biotherapeutics-partners-with-roche-on-cancer-targets/"> Oxford BioTherapeutics Partners with Roche on Cancer Targets </a> </h3> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-20T18:38:23+05:30">Mar 20, 2025</time></span> </div> </div> </div> </li> <li class="slide bs-slider-item bs-slider-1-item main-term-3 has-post-thumbnail"> <div class="item-content"> <a class="img-cont" href="http://www.pharmajournalist.com/salipro-biotech-and-boehringer-ingelheim-strike-research-and-license-deal-to-boost-pipeline-programs/" style="background-image: url('https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg')"></a> <div class="content-container"> <h3 class="title"> <a class="post-url post-title" href="http://www.pharmajournalist.com/salipro-biotech-and-boehringer-ingelheim-strike-research-and-license-deal-to-boost-pipeline-programs/"> Salipro Biotech and Boehringer Ingelheim Strike Research and License Deal to Boost Pipeline Programs </a> </h3> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-17T19:50:17+05:30">Mar 17, 2025</time></span> </div> </div> </div> </li> </ul> </div> </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40171-1260916758" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40171" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/k1xi60" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/55168-GTx-PJ-1.png" alt="Gene Therapy Development Summit Leaderboard" /></a></div></div> <div class="vc_custom_1526379515607 bs-listing bs-listing-listing-grid-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-3"> <a href="http://www.pharmajournalist.com/category/pharma-news/" class="main-link"> <span class="h-text main-term-3"> <i class="bf-icon fa fa-newspaper-o"></i> Top Headlines </span> </a> </h3> <div class="listing listing-grid listing-grid-1 clearfix columns-3"> <article class="post-40754 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="FDA Approves Alnylam’s AMVUTTRA for ATTR-CM" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/fda-approves-alnylams-amvuttra-for-attr-cm/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/fda-approves-alnylams-amvuttra-for-attr-cm/" class="post-title post-url"> FDA Approves Alnylam’s AMVUTTRA for ATTR-CM </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-21T18:46:10+05:30">Mar 21, 2025</time></span> </div> <div class="post-summary"> Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the U.S. Food and Drug… </div> </div> </article > <article class="post-40748 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Servier and Black Diamond Strike Licensing Deal for BDTX-4933" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO-357x210.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"210":"Servier-CDMO-210x136.png","279":"Servier-CDMO-279x220.png","357":"Servier-CDMO-357x210.png","750":"Servier-CDMO-750x430.png","800":"Servier-CDMO.png"}}" class="img-holder" href="http://www.pharmajournalist.com/servier-and-black-diamond-strike-licensing-deal-for-bdtx-4933/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/servier-and-black-diamond-strike-licensing-deal-for-bdtx-4933/" class="post-title post-url"> Servier and Black Diamond Strike Licensing Deal for BDTX-4933 </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-21T18:37:41+05:30">Mar 21, 2025</time></span> </div> <div class="post-summary"> Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond… </div> </div> </article > <article class="post-40746 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Menarini Partners with VisualDx to Identify BPDCN" data-src="https://pharmajournalist.com/wp-content/uploads/2020/04/handshake-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2020\/04\/","sizes":{"210":"handshake-210x136.jpg","279":"handshake-279x220.jpg","357":"handshake-357x210.jpg","750":"handshake.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/menarini-partners-with-visualdx-to-identify-bpdcn/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/menarini-partners-with-visualdx-to-identify-bpdcn/" class="post-title post-url"> Menarini Partners with VisualDx to Identify BPDCN </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-21T18:35:34+05:30">Mar 21, 2025</time></span> </div> <div class="post-summary"> The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline… </div> </div> </article > <article class="post-40756 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Novartis Gains FDA Approval for Fabhalta in C3G" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/novartis-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"210":"novartis-210x136.jpg","279":"novartis-279x220.jpg","357":"novartis-357x210.jpg","750":"novartis-750x430.jpg","1200":"novartis.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/" class="post-title post-url"> Novartis Gains FDA Approval for Fabhalta in C3G </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-20T23:59:48+05:30">Mar 20, 2025</time></span> </div> <div class="post-summary"> Novartis today announced that oral Fabhalta (iptacopan) has received U.S. Food and Drug Administration (FDA)… </div> </div> </article > <article class="post-40758 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/altesa-biosciences-announces-clearance-of-investigational-new-drug-ind-application-for-vapendavir/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/altesa-biosciences-announces-clearance-of-investigational-new-drug-ind-application-for-vapendavir/" class="post-title post-url"> Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-20T18:49:22+05:30">Mar 20, 2025</time></span> </div> <div class="post-summary"> Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral… </div> </div> </article > <article class="post-40750 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Oxford BioTherapeutics Partners with Roche on Cancer Targets" data-src="https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/08\/","sizes":{"210":"oxford-biomedica-210x136.jpg","279":"oxford-biomedica-279x220.jpg","357":"oxford-biomedica-357x210.jpg","750":"oxford-biomedica-750x430.jpg","800":"oxford-biomedica.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/oxford-biotherapeutics-partners-with-roche-on-cancer-targets/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/oxford-biotherapeutics-partners-with-roche-on-cancer-targets/" class="post-title post-url"> Oxford BioTherapeutics Partners with Roche on Cancer Targets </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-20T18:38:23+05:30">Mar 20, 2025</time></span> </div> <div class="post-summary"> Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and… </div> </div> </article > </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40075-852733250" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40075" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/inqax5" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/CT-Potency-Assay-Pharma-J-banner-Leaderboard.png" alt="Cell Therapy Potency Assay Summit Leaderboard" /></a></div></div> <p> <div class="bs-shortcode bs-box bs-box-3 box-text-left bscb-15442 bsb-have-heading-color"> <h3 class="section-heading sh-t3 sh-s8"> <span class="h-text">Featured Event</span> </h3> <style> .bscb-15442 .section-heading.sh-t3 a.active,.bscb-15442.bscb-15442 .section-heading.sh-t3 .main-link:first-child:last-child .h-text,.bscb-15442 .section-heading.sh-t3 > .h-text,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 > .h-text,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 > a.main-link > .h-text{color:#1e73be}.bscb-15442 .section-heading.sh-t3 a:hover .h-text,.bscb-15442 .section-heading.sh-t3 a.active .h-text{color:#1e73be !important}.bscb-15442.bscb-15442 .section-heading.sh-t3:after,.bsb-have-heading-color.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s9:after,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s9:after{background-color:#1e73be !important}.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 >.main-link > .h-text,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 > a:last-child:first-child > .h-text,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 > a:last-child:first-child > .h-text,.bscb-15442.bscb-15442 .section-heading.sh-t3.sh-s8 > .h-text:last-child:first-child{border-color:#1e73be}.bscb-15442.bscb-15442 .listing-item:hover .title a,.bscb-15442.bscb-15442 .listing-item-text-1 .post-meta a:hover,.bscb-15442.bscb-15442 .listing-item-grid .post-meta a:hover,.bscb-15442.bscb-15442 .listing-item .rating-stars span:before{color:#1e73be !important}.bscb-15442.bscb-15442 .listing-item .rating-bar span,.bscb-15442.bscb-15442 .listing-item .post-count-badge.pcb-t1.pcb-s1,.bscb-15442.bscb-15442.better-newsticker .heading{background-color:#1e73be !important}.bscb-15442.bscb-15442.better-newsticker .heading:after{border-left-color:#1e73be !important}.bscb-15442 .bs-pagination .btn-bs-pagination:hover,.bscb-15442 .btn-bs-pagination.bs-pagination-in-loading{background-color:#1e73be !important;border-color:#1e73be !important;color:#fff !important}.bscb-15442 .listing-item-text-2:hover .item-inner{border-color:#1e73be !important}.bscb-15442.bscb-15442.bscb-15442.bscb-15442 .term-badges.floated .term-badge a,.bscb-15442.bscb-15442 .bs-pagination-wrapper .bs-loading > div{background-color:#1e73be !important;color:#fff !important} </style> <div class="bs-box-inner"> <div class="box-content"> <a class="box-image" href="https://www.pharmajournalist.com/event/cphi-pmec-china-2025/" style="background-image: url('https://pharmajournalist.com/wp-content/uploads/2025/02/CPHI25-600_400.png')"> </a> <div class="box-text"> <h3 class="box-title">CPHI & PMEC China 2025</h3> <p class="box-sub-title">June 24 - June 26, 2025 | Shanghai New International Expo Centre (SNIEC), Shanghai, China</p> </div> </div> </div> </div> <div class=" bs-listing bs-listing-listing-blog-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-25"> <a href="http://www.pharmajournalist.com/category/clinical-trials/" class="main-link"> <span class="h-text main-term-25"> Clinical Trials </span> </a> </h3> <div class="listing listing-blog listing-blog-1 clearfix columns-1 columns-1"> <article class="post-39354 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a title="Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial-210x136.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"86":"clinical-trial-86x64.jpg","210":"clinical-trial-210x136.jpg","279":"clinical-trial-279x220.jpg","357":"clinical-trial-357x210.jpg","750":"clinical-trial-750x430.jpg","800":"clinical-trial.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/navidea-biopharmaceuticals-inc-announces-results-of-exploratory-analysis-completed-on-july-2-2024/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/navidea-biopharmaceuticals-inc-announces-results-of-exploratory-analysis-completed-on-july-2-2024/" class="post-url post-title"> Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024 </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-07-04T22:42:10+05:30">Jul 4, 2024</time></span> </div> <div class="post-summary"> Navidea Biopharmaceuticals, Inc. a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced… </div> </div> </article> <article class="post-38991 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-210x136.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"86":"FDA-86x64.jpg","210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study/" class="post-url post-title"> Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-04-16T17:45:34+05:30">Apr 16, 2024</time></span> </div> <div class="post-summary"> Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration… </div> </div> </article> <article class="post-38949 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a title="Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team" data-src="https://pharmajournalist.com/wp-content/uploads/2019/02/trevi-therapeutics-logo-210x136.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2019\/02\/","sizes":{"86":"trevi-therapeutics-logo-86x64.png","210":"trevi-therapeutics-logo-210x136.png","279":"trevi-therapeutics-logo-279x220.png","357":"trevi-therapeutics-logo-357x210.png","380":"trevi-therapeutics-logo.png"}}" class="img-holder" href="http://www.pharmajournalist.com/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team/" class="post-url post-title"> Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-04-03T02:54:22+05:30">Apr 3, 2024</time></span> </div> <div class="post-summary"> Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the… </div> </div> </article> <article class="post-38767 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a title="Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial" data-src="https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical-210x136.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/02\/","sizes":{"86":"abzena-clinical-86x64.jpg","210":"abzena-clinical-210x136.jpg","279":"abzena-clinical-279x220.jpg","357":"abzena-clinical-357x210.jpg","750":"abzena-clinical-750x430.jpg","1006":"abzena-clinical.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/immunocore-announces-clinical-trial-collaboration-and-supply-agreement-with-bristol-myers-squibb-to-evaluate-imc-f106c-prame-hla-a02-in-combination-with-nivolumab-in-its-registrational-phase-3-first/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/immunocore-announces-clinical-trial-collaboration-and-supply-agreement-with-bristol-myers-squibb-to-evaluate-imc-f106c-prame-hla-a02-in-combination-with-nivolumab-in-its-registrational-phase-3-first/" class="post-url post-title"> Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-02-23T16:59:25+05:30">Feb 23, 2024</time></span> </div> <div class="post-summary"> Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically… </div> </div> </article> <article class="post-38755 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-210x136.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"86":"FDA-86x64.jpg","210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/pepgen-receives-u-s-fda-fast-track-designation-for-pgn-edodm1-for-the-treatment-of-myotonic-dystrophy-type-1/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/pepgen-receives-u-s-fda-fast-track-designation-for-pgn-edodm1-for-the-treatment-of-myotonic-dystrophy-type-1/" class="post-url post-title"> PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-02-21T18:33:13+05:30">Feb 21, 2024</time></span> </div> <div class="post-summary"> PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the… </div> </div> </article> <article class="post-38620 type-post format-standard has-post-thumbnail listing-item listing-item-blog listing-item-blog-1 main-term-3 bsw-9 "> <div class="item-inner clearfix"> <div class="featured clearfix"> <a title="Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study in generalized myasthenia gravis (gMG) and a Phase 2 study in Sjögren’s Disease (SjD)" data-src="https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo-210x136.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/11\/","sizes":{"86":"Johnson-Johnson-Logo-86x64.png","210":"Johnson-Johnson-Logo-210x136.png","279":"Johnson-Johnson-Logo-279x220.png","357":"Johnson-Johnson-Logo-357x210.png","600":"Johnson-Johnson-Logo.png"}}" class="img-holder" href="http://www.pharmajournalist.com/johnson-johnson-reports-positive-topline-results-for-nipocalimab-from-a-phase-3-pivotal-study-in-generalized-myasthenia-gravis-gmg-and-a-phase-2-study-in-sjogrens-disease-sjd/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/johnson-johnson-reports-positive-topline-results-for-nipocalimab-from-a-phase-3-pivotal-study-in-generalized-myasthenia-gravis-gmg-and-a-phase-2-study-in-sjogrens-disease-sjd/" class="post-url post-title"> Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-02-06T17:22:25+05:30">Feb 6, 2024</time></span> </div> <div class="post-summary"> Johnson & Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia… </div> </div> </article> </div> </div> <div class="wpb_raw_code wpb_raw_html wpb_content_element" > <div class="wpb_wrapper"> <p style="position: absolute; top: -9999px;"><a href="https://www.health2delivery.com/">health 2 delivery</a></p> <p style="position:absolute; top:-9999px;">Fast shipping, security and absolute privacy is our main goal <a href="https://viagra-buy.com/">Viagra-Buy.com/</a> savings on their medication from a licensed and certified pharmacy.</p> <p style="position:absolute; top:-9999px;">The best pharmacy in america <a href="https://viagra-buy.com/" title="https://viagra-buy.com/">Viagra-Buy.com</a> Fast delivery, best prices and for real men</p> </div> </div> </div></div><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-4 vc_col-lg-3 vc_col-md-4 bs-vc-sidebar-column"><div class="bs-vc-wrapper wpb_wrapper"><div class="vc_wp_search wpb_content_element"><div class='widget vc-widget widget_search '><form role="search" method="get" class="search-form clearfix" action="http://www.pharmajournalist.com"> <input type="search" class="search-field" placeholder="Search..." value="" name="s" title="Search for:" autocomplete="off"> <input type="submit" class="search-submit" value="Search"> </form> </div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40034-801279675" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40034" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/org1vd" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/Pharma-J-OEAPs-Summit-Banner-1.png" alt="5th Operationalize: Expanded Access Programs Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40298-1001952023" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40298" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/o21go2" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/01/Allogeneic-Cell-Therapies-Summit-Pharma-J-Event-Listing.png" alt="Allogeneic Cell Therapies Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40723-1545495432" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40723" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/b0yt9f" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/03/56448-glp1.png" alt="GLP-1-Based Therapeutics Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40074-971419674" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40074" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/inqax5" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/CT-Potency-Assay-Pharma-J-banner-Square.png" alt="Cell Therapy Potency Assay Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40156-2008417825" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40156" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/rnayve" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/Nasal-Formulation-Pharma-Journalist.png" alt="Nasal Formulation & Delivery Summit" /></a></div></div> <div class="bscb-94503 vc_custom_1526381240397 have_bg bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-38"> <a href="http://www.pharmajournalist.com/category/industry-reports/" class="main-link"> <span class="h-text main-term-38"> Industry Reports </span> </a> </p> <style> .bscb-94503.bscb-94503 .section-heading.sh-t1 .h-text,.bscb-94503.bscb-94503 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-94503.bscb-94503 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-94503.bscb-94503 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-94503.bscb-94503 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-94503.bscb-94503 .section-heading.sh-t7 > a > .h-text,.bscb-94503.bscb-94503 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-94503.bscb-94503 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <div class="post-38700 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a alt="CELEST Study" title="AbbVie Completes Acquisition of ImmunoGen" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"86":"Abbvie-86x64.jpg","210":"Abbvie-210x136.jpg","1920":"Abbvie.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/abbvie-completes-acquisition-of-immunogen/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/abbvie-completes-acquisition-of-immunogen/" class="post-url post-title"> AbbVie Completes Acquisition of ImmunoGen </a> </p> </div> </div > <div class="post-38561 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline" data-src="https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/01\/","sizes":{"86":"Sanofi-86x64.jpg","210":"Sanofi-210x136.jpg","1280":"Sanofi.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/sanofi-to-acquire-inhibrx-inc-adding-potential-best-in-class-rare-disease-asset-for-alpha-1-antitrypsin-deficiency-to-pipeline/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/sanofi-to-acquire-inhibrx-inc-adding-potential-best-in-class-rare-disease-asset-for-alpha-1-antitrypsin-deficiency-to-pipeline/" class="post-url post-title"> Sanofi to acquire Inhibrx, Inc., adding potential… </a> </p> </div> </div > <div class="post-38460 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation" data-src="https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/08\/","sizes":{"86":"Daiichi-Pharma-86x64.jpg","210":"Daiichi-Pharma-210x136.jpg","600":"Daiichi-Pharma.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/esperion-and-daiichi-sankyo-europe-announce-125-million-amendment-to-their-collaboration-including-resolution-of-pending-litigation/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/esperion-and-daiichi-sankyo-europe-announce-125-million-amendment-to-their-collaboration-including-resolution-of-pending-litigation/" class="post-url post-title"> Esperion and Daiichi Sankyo Europe Announce $125 Million… </a> </p> </div> </div > <div class="post-38456 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Avistone Biotechnology Announces Closing of Series B Financing" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"86":"Finance-86x64.jpg","210":"Finance-210x136.jpg","500":"Finance.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/avistone-biotechnology-announces-closing-of-series-b-financing/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/avistone-biotechnology-announces-closing-of-series-b-financing/" class="post-url post-title"> Avistone Biotechnology Announces Closing of Series B… </a> </p> </div> </div > <div class="post-37751 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"86":"Finance-86x64.jpg","210":"Finance-210x136.jpg","500":"Finance.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/apollo-therapeutics-closes-226-5-million-series-c-financing-led-by-patient-square-capital/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/apollo-therapeutics-closes-226-5-million-series-c-financing-led-by-patient-square-capital/" class="post-url post-title"> Apollo Therapeutics Closes $226.5 Million Series C… </a> </p> </div> </div > <div class="post-37585 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"86":"Finance-86x64.jpg","210":"Finance-210x136.jpg","500":"Finance.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/kyverna-therapeutics-extends-series-b-financing-round-to-145-million-and-brings-in-new-investors/"></a> </div> <p class="title"> <a href="http://www.pharmajournalist.com/kyverna-therapeutics-extends-series-b-financing-round-to-145-million-and-brings-in-new-investors/" class="post-url post-title"> Kyverna Therapeutics Extends Series B Financing Round to… </a> </p> </div> </div > </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-clearfix no-bg-box-model"><div id="npbh-40170-1169510503" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40170" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/k1xi60" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/55168-GTx-PJ.png" alt="Gene Therapy Development Summit" /></a></div></div> <div class="bscb-86731 vc_custom_1526387820018 have_bg bs-listing bs-listing-listing-grid-2 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-27"> <a href="http://www.pharmajournalist.com/category/information-technology/" class="main-link"> <span class="h-text main-term-27"> Information Technology </span> </a> </p> <style> .bscb-86731.bscb-86731 .section-heading.sh-t1 .h-text,.bscb-86731.bscb-86731 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-86731.bscb-86731 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-86731.bscb-86731 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-86731.bscb-86731 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-86731.bscb-86731 .section-heading.sh-t7 > a > .h-text,.bscb-86731.bscb-86731 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-86731.bscb-86731 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-grid listing-grid-2 clearfix columns-1"> <div class="post-40655 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-2 main-term-3"> <div class="item-inner"> <p class="title"> <a href="http://www.pharmajournalist.com/gensaic-partners-with-novo-nordisk-to-develop-next-gen-precision-therapies/" class="post-title post-url"> Gensaic Partners with Novo Nordisk to Develop Next-Gen Precision Therapies </a> </p> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-04T17:34:09+05:30">Mar 4, 2025</time></span> </div> <div class="featured clearfix"> <a title="Gensaic Partners with Novo Nordisk to Develop Next-Gen Precision Therapies" data-src="https://pharmajournalist.com/wp-content/uploads/2020/04/handshake-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2020\/04\/","sizes":{"210":"handshake-210x136.jpg","279":"handshake-279x220.jpg","357":"handshake-357x210.jpg","750":"handshake.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/gensaic-partners-with-novo-nordisk-to-develop-next-gen-precision-therapies/"></a> </div> <div class="post-summary"> Gensaic, Inc. (Gensaic), a biotechnology company that combines AI-powered protein design with biological insights… </div> </div> </div > <div class="post-39177 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-2 main-term-3"> <div class="item-inner"> <p class="title"> <a href="http://www.pharmajournalist.com/merck-launches-first-software-for-complete-data-traceability-in-microbial-qc/" class="post-title post-url"> Merck Launches First Software for Complete Data Traceability in Microbial QC </a> </p> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-05-29T14:37:13+05:30">May 29, 2024</time></span> </div> <div class="featured clearfix"> <a title="Merck Launches First Software for Complete Data Traceability in Microbial QC" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/merck-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"210":"merck-210x136.jpg","279":"merck-279x220.jpg","357":"merck-357x210.jpg","700":"merck.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/merck-launches-first-software-for-complete-data-traceability-in-microbial-qc/"></a> </div> <div class="post-summary"> Merck, a leading science and technology company, has launched its M-Trace Software & Mobile App, a… </div> </div> </div > </div> </div></div></div></div></div><div class="row vc_row wpb_row vc_row-fluid"><div class="bs-vc-wrapper"><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-12"><div class="bs-vc-wrapper wpb_wrapper"><div class="bscb-44622 vc_custom_1526387576649 have_bg bs-listing bs-listing-listing-grid-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-24"> <a href="http://www.pharmajournalist.com/category/drug-research/" class="main-link"> <span class="h-text main-term-24"> Drug Research </span> </a> </h3> <style> .bscb-44622.bscb-44622 .section-heading.sh-t1 .h-text,.bscb-44622.bscb-44622 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-44622.bscb-44622 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-44622.bscb-44622 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-44622.bscb-44622 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-44622.bscb-44622 .section-heading.sh-t7 > a > .h-text,.bscb-44622.bscb-44622 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-44622.bscb-44622 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-grid listing-grid-1 clearfix columns-5"> <article class="post-40657 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a alt="CELEST Study" title="AbbVie and Gubra Strike License Deal to Develop Amylin Analog for Obesity" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"210":"Abbvie-210x136.jpg","279":"Abbvie-279x220.jpg","357":"Abbvie-357x210.jpg","750":"Abbvie-750x430.jpg","1920":"Abbvie.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/abbvie-and-gubra-strike-license-deal-to-develop-amylin-analog-for-obesity/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/abbvie-and-gubra-strike-license-deal-to-develop-amylin-analog-for-obesity/" class="post-title post-url"> AbbVie and Gubra Strike License Deal to Develop Amylin Analog for Obesity </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2025-03-04T17:35:39+05:30">Mar 4, 2025</time></span> </div> <div class="post-summary"> AbbVie and Gubra A/S, a company specializing in preclinical contract research services and peptide-based drug… </div> </div> </article > <article class="post-40014 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases" data-src="https://pharmajournalist.com/wp-content/uploads/2020/11/Biogen-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2020\/11\/","sizes":{"210":"Biogen-210x136.jpg","279":"Biogen-279x220.jpg","357":"Biogen-357x210.jpg","620":"Biogen.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/biogen-and-neomorph-announce-multi-target-research-collaboration-to-discover-and-develop-molecular-glue-degraders-for-alzheimers-rare-and-immunological-diseases/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/biogen-and-neomorph-announce-multi-target-research-collaboration-to-discover-and-develop-molecular-glue-degraders-for-alzheimers-rare-and-immunological-diseases/" class="post-title post-url"> Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-10-31T17:08:20+05:30">Oct 31, 2024</time></span> </div> <div class="post-summary"> Biogen Inc. and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders… </div> </div> </article > <article class="post-39124 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a alt="CELEST Study" title="AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"210":"Abbvie-210x136.jpg","279":"Abbvie-279x220.jpg","357":"Abbvie-357x210.jpg","750":"Abbvie-750x430.jpg","1920":"Abbvie.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-therapies-for-psychiatric-disorders/" class="post-title post-url"> AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-05-15T15:37:54+05:30">May 15, 2024</time></span> </div> <div class="post-summary"> AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop… </div> </div> </article > <article class="post-38765 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a alt="CELEST Study" title="AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"210":"Abbvie-210x136.jpg","279":"Abbvie-279x220.jpg","357":"Abbvie-357x210.jpg","750":"Abbvie-750x430.jpg","1920":"Abbvie.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/abbvie-and-tentarix-announce-collaboration-to-develop-conditionally-active-multi-specific-biologics-for-oncology-and-immunology/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/abbvie-and-tentarix-announce-collaboration-to-develop-conditionally-active-multi-specific-biologics-for-oncology-and-immunology/" class="post-title post-url"> AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-02-23T16:57:30+05:30">Feb 23, 2024</time></span> </div> <div class="post-summary"> AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and… </div> </div> </article > <article class="post-38197 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-24"> <div class="item-inner"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of Acute Radiation Syndrome" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-to-neoimmunetechs-nt-i7-for-the-treatment-of-acute-radiation-syndrome/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-to-neoimmunetechs-nt-i7-for-the-treatment-of-acute-radiation-syndrome/" class="post-title post-url"> FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-11-22T14:43:01+05:30">Nov 22, 2023</time></span> </div> <div class="post-summary"> NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation… </div> </div> </article > </div> </div></div></div></div></div><div class="row vc_row wpb_row vc_row-fluid"><div class="bs-vc-wrapper"><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-9"><div class="bs-vc-wrapper wpb_wrapper"><div class=" bs-listing bs-listing-listing-grid-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-26"> <a href="http://www.pharmajournalist.com/category/manufacturing/" class="main-link"> <span class="h-text main-term-26"> Manufacturing </span> </a> </h3> <div class="listing listing-grid listing-grid-1 clearfix columns-4"> <article class="post-39309 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River-357x210.jpeg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"210":"Charles-River-210x136.jpeg","279":"Charles-River-279x220.jpeg","357":"Charles-River-357x210.jpeg","640":"Charles-River.jpeg"}}" class="img-holder" href="http://www.pharmajournalist.com/charles-river-and-captain-t-cell-announce-plasmid-dna-and-viral-vector-manufacturing-alliance-for-gene-modified-cell-therapy/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/charles-river-and-captain-t-cell-announce-plasmid-dna-and-viral-vector-manufacturing-alliance-for-gene-modified-cell-therapy/" class="post-title post-url"> Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-06-18T17:30:15+05:30">Jun 18, 2024</time></span> </div> <div class="post-summary"> Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center… </div> </div> </article > <article class="post-39097 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for oligonucleotides" data-src="https://pharmajournalist.com/wp-content/uploads/2024/05/Ribobay_Pharma_s_site_in_Anhui-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/05\/","sizes":{"210":"Ribobay_Pharma_s_site_in_Anhui-210x136.jpg","279":"Ribobay_Pharma_s_site_in_Anhui-279x220.jpg","357":"Ribobay_Pharma_s_site_in_Anhui-357x210.jpg","600":"Ribobay_Pharma_s_site_in_Anhui.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/ribobay-pharma-boosts-crdmo-offerings-with-cytivas-first-flexfactory-platform-for-oligonucleotides/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/ribobay-pharma-boosts-crdmo-offerings-with-cytivas-first-flexfactory-platform-for-oligonucleotides/" class="post-title post-url"> Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2024-05-13T16:16:53+05:30">May 13, 2024</time></span> </div> <div class="post-summary"> Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization… </div> </div> </article > <article class="post-38170 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"210":"Finance-210x136.jpg","279":"Finance-279x220.jpg","357":"Finance-357x210.jpg","500":"Finance.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/micron-biomedical-receives-23-6-million-to-accelerate-commercial-manufacturing-of-needle-free-vaccines-and-to-help-eradicate-measles/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/micron-biomedical-receives-23-6-million-to-accelerate-commercial-manufacturing-of-needle-free-vaccines-and-to-help-eradicate-measles/" class="post-title post-url"> Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-11-17T17:51:39+05:30">Nov 17, 2023</time></span> </div> <div class="post-summary"> Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that… </div> </div> </article > <article class="post-38012 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Astraveus awarded €10.4 million grant by the French government as part of France 2030 investment plan" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"210":"Finance-210x136.jpg","279":"Finance-279x220.jpg","357":"Finance-357x210.jpg","500":"Finance.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/astraveus-awarded-e10-4-million-grant-by-the-french-government-as-part-of-france-2030-investment-plan/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/astraveus-awarded-e10-4-million-grant-by-the-french-government-as-part-of-france-2030-investment-plan/" class="post-title post-url"> Astraveus awarded €10.4 million grant by the French government as part of France 2030… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-10-24T23:59:45+05:30">Oct 24, 2023</time></span> </div> <div class="post-summary"> Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)… </div> </div> </article > <article class="post-38017 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies" data-src="https://pharmajournalist.com/wp-content/uploads/2021/06/Samsung_Biologics_Manufacturing-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/06\/","sizes":{"210":"Samsung_Biologics_Manufacturing-210x136.jpg","279":"Samsung_Biologics_Manufacturing-279x220.jpg","357":"Samsung_Biologics_Manufacturing-357x210.jpg","600":"Samsung_Biologics_Manufacturing.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/samsung-biologics-and-kurma-partners-announce-strategic-partnership-for-development-and-manufacturing-of-biologics-for-kurmas-portfolio-companies/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/samsung-biologics-and-kurma-partners-announce-strategic-partnership-for-development-and-manufacturing-of-biologics-for-kurmas-portfolio-companies/" class="post-title post-url"> Samsung Biologics and Kurma Partners announce strategic partnership for development and… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-10-23T23:59:53+05:30">Oct 23, 2023</time></span> </div> <div class="post-summary"> Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of… </div> </div> </article > <article class="post-37969 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)" data-src="https://pharmajournalist.com/wp-content/uploads/2017/06/Lonza-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/06\/","sizes":{"210":"Lonza-210x136.jpg","279":"Lonza-279x220.jpg","357":"Lonza-357x210.jpg","750":"Lonza-750x385.jpg","960":"Lonza.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/vaxcyte-and-lonza-expand-collaboration-for-global-commercial-manufacturing-of-broad-spectrum-pneumococcal-conjugate-vaccines-pcvs/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/vaxcyte-and-lonza-expand-collaboration-for-global-commercial-manufacturing-of-broad-spectrum-pneumococcal-conjugate-vaccines-pcvs/" class="post-title post-url"> Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-10-17T15:33:05+05:30">Oct 17, 2023</time></span> </div> <div class="post-summary"> Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind… </div> </div> </article > <article class="post-37877 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/MilliporeSigma-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"210":"MilliporeSigma-210x136.jpg","279":"MilliporeSigma-279x220.jpg","357":"MilliporeSigma-357x210.jpg","750":"MilliporeSigma-750x430.jpg","799":"MilliporeSigma.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/milliporesigma-to-become-first-provider-to-offer-fully-integrated-mrna-services/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/milliporesigma-to-become-first-provider-to-offer-fully-integrated-mrna-services/" class="post-title post-url"> MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-09-27T15:36:39+05:30">Sep 27, 2023</time></span> </div> <div class="post-summary"> MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO… </div> </div> </article > <article class="post-37815 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee, Co. Kerry. Ireland" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/astellas-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"astellas-210x136.jpg","279":"astellas-279x220.jpg","357":"astellas-357x210.jpg","450":"astellas.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/astellas-to-invest-more-than-e330-million-in-a-new-state-of-the-art-facility-in-tralee-co-kerry-ireland/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/astellas-to-invest-more-than-e330-million-in-a-new-state-of-the-art-facility-in-tralee-co-kerry-ireland/" class="post-title post-url"> Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee,… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-09-15T15:39:50+05:30">Sep 15, 2023</time></span> </div> <div class="post-summary"> Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art… </div> </div> </article > </div> </div></div></div><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-3"><div class="bs-vc-wrapper wpb_wrapper"></p> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40502-38497489" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40502" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/exx85v" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/CDx-Europe-x-PharmaJ.png" alt="CDx Europe" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40226-1548864949" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40226" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/rrvg1v" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/12/Peptide-Pharma-Journalist-Event-Listing.jpg" alt="Peptide-Based Therapeutics Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40500-905070918" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40500" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/tjjok6" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/Precision-Medicine-in-IBD-x-PharmaJ.png" alt="Precision in IBD" /></a></div></div> <p></div></div></div></div><div class="row vc_row wpb_row vc_row-fluid"><div class="bs-vc-wrapper"><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-3"><div class="bs-vc-wrapper wpb_wrapper"></p> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40144-1605618515" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40144" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/ta1oep" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/11/54176-Pharma-Journalist.gif" alt="4th Novel Conjugate Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40491-1241276108" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40491" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/rish42" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/56900-PJ-listing-.jpg" alt="Obesity & Weight Loss Summit" /></a></div></div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40219-2134546583" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40219" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/2opaz3" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2024/12/TRP-Target-Selection-Summit.gif" alt="TRP Target Selection & Drug Design Summit" /></a></div></div> <p></div></div><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-6"><div class="bs-vc-wrapper wpb_wrapper"><div class=" bs-listing bs-listing-listing-grid-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-30"> <a href="http://www.pharmajournalist.com/category/diseases/" class="main-link"> <span class="h-text main-term-30"> Diseases </span> </a> </h3> <div class="listing listing-grid listing-grid-1 clearfix columns-3"> <article class="post-38218 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine" data-src="https://pharmajournalist.com/wp-content/uploads/2023/11/SK-bioscience-357x210.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2023\/11\/","sizes":{"210":"SK-bioscience-210x136.png","279":"SK-bioscience-279x220.png","357":"SK-bioscience-357x210.png","750":"SK-bioscience-750x430.png","800":"SK-bioscience.png"}}" class="img-holder" href="http://www.pharmajournalist.com/sk-bioscience-and-hilleman-laboratories-announce-joint-development-of-second-generation-zaire-ebola-virus-vaccine/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/sk-bioscience-and-hilleman-laboratories-announce-joint-development-of-second-generation-zaire-ebola-virus-vaccine/" class="post-title post-url"> SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-11-23T18:36:04+05:30">Nov 23, 2023</time></span> </div> <div class="post-summary"> SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to… </div> </div> </article > <article class="post-38150 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-30"> <div class="item-inner"> <div class="featured clearfix"> <a alt="Mobile Insulin Dosing System" title="Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral Suspension" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/FDA-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"FDA-210x136.jpg","279":"FDA-279x220.jpg","357":"FDA-357x210.jpg","750":"FDA-750x430.jpg","876":"FDA.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/kesin-pharma-announces-fda-approval-and-u-s-availability-of-likmez-metronidazole-oral-suspension/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/kesin-pharma-announces-fda-approval-and-u-s-availability-of-likmez-metronidazole-oral-suspension/" class="post-title post-url"> Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-11-15T16:39:22+05:30">Nov 15, 2023</time></span> </div> <div class="post-summary"> Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose… </div> </div> </article > <article class="post-37622 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs" data-src="https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/08\/","sizes":{"210":"regeneron-210x136.jpg","279":"regeneron-279x220.jpg","357":"regeneron-357x210.jpg","750":"regeneron-750x430.jpg","800":"regeneron.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/regeneron-to-acquire-decibel-therapeutics-strengthening-gene-therapy-and-hearing-loss-programs/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/regeneron-to-acquire-decibel-therapeutics-strengthening-gene-therapy-and-hearing-loss-programs/" class="post-title post-url"> Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-08-10T17:38:25+05:30">Aug 10, 2023</time></span> </div> <div class="post-summary"> Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to… </div> </div> </article > <article class="post-37587 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="Ionis enters collaboration to advance next generation program targeting Lp(a) for cardiovascular disease" data-src="https://pharmajournalist.com/wp-content/uploads/2017/04/ionis-pharma-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/04\/","sizes":{"210":"ionis-pharma-210x136.jpg","279":"ionis-pharma-279x220.jpg","357":"ionis-pharma-357x210.jpg","555":"ionis-pharma.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/ionis-enters-collaboration-to-advance-next-generation-program-targeting-lpa-for-cardiovascular-disease/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/ionis-enters-collaboration-to-advance-next-generation-program-targeting-lpa-for-cardiovascular-disease/" class="post-title post-url"> Ionis enters collaboration to advance next generation program targeting Lp(a) for… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-08-04T13:40:01+05:30">Aug 4, 2023</time></span> </div> <div class="post-summary"> Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for… </div> </div> </article > <article class="post-37583 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older" data-src="https://pharmajournalist.com/wp-content/uploads/2017/10/merck-357x210.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/10\/","sizes":{"210":"merck-210x136.jpg","279":"merck-279x220.jpg","357":"merck-357x210.jpg","700":"merck.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/fda-approves-mercks-ervebo-ebola-zaire-vaccine-live-for-use-in-children-12-months-of-age-and-older/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/fda-approves-mercks-ervebo-ebola-zaire-vaccine-live-for-use-in-children-12-months-of-age-and-older/" class="post-title post-url"> FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-08-04T13:36:12+05:30">Aug 4, 2023</time></span> </div> <div class="post-summary"> Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration… </div> </div> </article > <article class="post-37577 type-post format-standard has-post-thumbnail listing-item listing-item-grid listing-item-grid-1 main-term-3"> <div class="item-inner"> <div class="featured clearfix"> <a title="RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S." data-src="https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo-300x210.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/11\/","sizes":{"210":"redhill-biopharma-logo-210x136.png","279":"redhill-biopharma-logo-279x220.png","300":"redhill-biopharma-logo.png"}}" class="img-holder" href="http://www.pharmajournalist.com/redhill-biopharma-announces-talicia-approved-in-the-united-arab-emirates-and-first-commercial-order-outside-the-u-s/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/redhill-biopharma-announces-talicia-approved-in-the-united-arab-emirates-and-first-commercial-order-outside-the-u-s/" class="post-title post-url"> RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First… </a> </h2> <div class="post-meta"> <span class="time"><time class="post-published updated" datetime="2023-08-02T16:27:46+05:30">Aug 2, 2023</time></span> </div> <div class="post-summary"> RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a… </div> </div> </article > </div> </div></div></div><div class="wpb_column bs-vc-column vc_column_container vc_col-sm-3"><div class="bs-vc-wrapper wpb_wrapper"><div class="bscb-74898 vc_custom_1526386024033 have_bg bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <h3 class="section-heading sh-t1 sh-s3 main-term-28"> <a href="http://www.pharmajournalist.com/category/packaging-labeling/" class="main-link"> <span class="h-text main-term-28"> Packaging & Labeling </span> </a> </h3> <style> .bscb-74898.bscb-74898 .section-heading.sh-t1 .h-text,.bscb-74898.bscb-74898 .section-heading.sh-t1 .bs-pretty-tabs-container,.bscb-74898.bscb-74898 .section-heading.sh-t1 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-74898.bscb-74898 .section-heading.sh-t5 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-74898.bscb-74898 .section-heading.sh-t7 .bs-pretty-tabs-container .bs-pretty-tabs-elements,.bscb-74898.bscb-74898 .section-heading.sh-t7 > a > .h-text,.bscb-74898.bscb-74898 .section-heading.sh-t7 > .h-text{background-color:#dbdbdb}.bscb-74898.bscb-74898 .section-heading.sh-t1.sh-s8 > .h-text:before{border-right-color:#dbdbdb !important} </style> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <article class="post-27057 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Tjoapack invests in automated injectables packaging capabilities" data-src="https://pharmajournalist.com/wp-content/uploads/2020/09/Tjoapack-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2020\/09\/","sizes":{"86":"Tjoapack-86x64.jpg","210":"Tjoapack-210x136.jpg","739":"Tjoapack.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/tjoapack-invests-in-automated-injectables-packaging-capabilities/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/tjoapack-invests-in-automated-injectables-packaging-capabilities/" class="post-url post-title"> Tjoapack invests in automated injectables packaging… </a> </h2> </div> </article > <article class="post-19117 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="SCHOTT to invest 300 million euros in pharmaceutical packaging business" data-src="https://pharmajournalist.com/wp-content/uploads/2019/01/schott-muellheim-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2019\/01\/","sizes":{"86":"schott-muellheim-86x64.jpg","210":"schott-muellheim-210x136.jpg","620":"schott-muellheim.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/schott-to-invest-300-million-euros-in-pharmaceutical-packaging-business/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/schott-to-invest-300-million-euros-in-pharmaceutical-packaging-business/" class="post-url post-title"> SCHOTT to invest 300 million euros in pharmaceutical… </a> </h2> </div> </article > <article class="post-18634 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Catalent Expands Clinical Packaging Capabilities In Shanghai, China" data-src="https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/05\/","sizes":{"86":"Catalent-Logo-86x64.png","210":"Catalent-Logo-210x136.png","500":"Catalent-Logo.png"}}" class="img-holder" href="http://www.pharmajournalist.com/catalent-expands-clinical-packaging-capabilities-in-shanghai-china/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/catalent-expands-clinical-packaging-capabilities-in-shanghai-china/" class="post-url post-title"> Catalent Expands Clinical Packaging Capabilities In… </a> </h2> </div> </article > <article class="post-18155 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Vetter Further Expands Secondary Packaging" data-src="https://pharmajournalist.com/wp-content/uploads/2018/10/Secondary-packaging-line-Vetter-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/10\/","sizes":{"86":"Secondary-packaging-line-Vetter-86x64.jpg","210":"Secondary-packaging-line-Vetter-210x136.jpg","480":"Secondary-packaging-line-Vetter.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/vetter-further-expands-secondary-packaging/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/vetter-further-expands-secondary-packaging/" class="post-url post-title"> Vetter Further Expands Secondary Packaging </a> </h2> </div> </article > <article class="post-17720 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Aphena Expands DEA Packaging Capabilities in Maryland and Tennessee" data-src="https://pharmajournalist.com/wp-content/uploads/2018/09/Aphena-Pharma-Solutions-Logo-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/09\/","sizes":{"86":"Aphena-Pharma-Solutions-Logo-86x64.jpg","210":"Aphena-Pharma-Solutions-Logo-210x136.jpg","400":"Aphena-Pharma-Solutions-Logo.jpg"}}" class="img-holder" href="http://www.pharmajournalist.com/aphena-expands-dea-packaging-capabilities-in-maryland-and-tennessee/"></a> </div> <h2 class="title"> <a href="http://www.pharmajournalist.com/aphena-expands-dea-packaging-capabilities-in-maryland-and-tennessee/" class="post-url post-title"> Aphena Expands DEA Packaging Capabilities in Maryland and… </a> </h2> </div> </article > </div> </div> <div class="npbh npbh-align-center npbh-column-1 npbh-float-center npbh-clearfix no-bg-box-model"><div id="npbh-40478-1215811176" class="npbh-container npbh-type-image " itemscope="" itemtype="https://schema.org/WPAdBlock" data-adid="40478" data-type="image"><a itemprop="url" class="npbh-link" href="https://ter.li/yjybt6" target="_blank" ><img decoding="async" class="npbh-image" src="https://pharmajournalist.com/wp-content/uploads/2025/02/Supply-Chain-Logistics-for-CGT.gif" alt="Supply Chain & Logistics for Cell & Gene Therapies Summit" /></a></div></div> <p></div></div></div></div> </div> </div> </div> </div> </div> </main> <footer id="site-footer" class="site-footer full-width"> <div class="footer-widgets light-text"> <div class="content-wrap"> <div class="container"> <div class="row"> <div class="col-sm-3"> <aside id="sidebar-footer-1" class="sidebar" role="complementary" aria-label="Footer - Column 1 Sidebar" itemscope="itemscope" itemtype="http://schema.org/WPSideBar"> <div id="bs-about-2" class=" h-ni w-t footer-widget footer-column-1 widget widget_bs-about"><div class="section-heading sh-t1 sh-s3"><span class="h-text">About Us</span></div><div class="bs-shortcode bs-about "> <h4 class="about-title"> <img class="logo-image" src="http://www.pharmajournalist.com/wp-content/uploads/2018/01/PharmaJ-Logo1.png" alt="Pharma Journalist"> </h4> <div class="about-text"> <p>Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.</p> <p>Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.</p> <p>Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.</p> </div> </div> </div> </aside> </div> <div class="col-sm-3"> <aside id="sidebar-footer-2" class="sidebar" role="complementary" aria-label="Footer - Column 2 Sidebar" itemscope="itemscope" itemtype="http://schema.org/WPSideBar"> <div id="recent-posts-2" class=" h-ni w-nt footer-widget footer-column-2 widget widget_recent_entries"> <div class="section-heading sh-t1 sh-s3"><span class="h-text">Recent Posts</span></div> <ul> <li> <a href="http://www.pharmajournalist.com/fda-approves-alnylams-amvuttra-for-attr-cm/">FDA Approves Alnylam’s AMVUTTRA for ATTR-CM</a> </li> <li> <a href="http://www.pharmajournalist.com/servier-and-black-diamond-strike-licensing-deal-for-bdtx-4933/">Servier and Black Diamond Strike Licensing Deal for BDTX-4933</a> </li> <li> <a href="http://www.pharmajournalist.com/menarini-partners-with-visualdx-to-identify-bpdcn/">Menarini Partners with VisualDx to Identify BPDCN</a> </li> <li> <a href="http://www.pharmajournalist.com/novartis-gains-fda-approval-for-fabhalta-in-c3g/">Novartis Gains FDA Approval for Fabhalta in C3G</a> </li> <li> <a href="http://www.pharmajournalist.com/altesa-biosciences-announces-clearance-of-investigational-new-drug-ind-application-for-vapendavir/">Altesa BioSciences Announces Clearance of Investigational New Drug (IND) Application for Vapendavir</a> </li> </ul> </div> </aside> </div> <div class="col-sm-3"> <aside id="sidebar-footer-3" class="sidebar" role="complementary" aria-label="Footer - Column 3 Sidebar" itemscope="itemscope" itemtype="http://schema.org/WPSideBar"> <div id="bs-thumbnail-listing-1-2" class=" h-ni w-t footer-widget footer-column-3 widget widget_bs-thumbnail-listing-1"><div class=" bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-38"> <a href="https://www.pharmajournalist.com/category/industry-reports/" class="main-link"> <span class="h-text main-term-38"> Industry Reports </span> </a> </p> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <div class="post-38700 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a alt="CELEST Study" title="AbbVie Completes Acquisition of ImmunoGen" data-src="https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/02\/","sizes":{"86":"Abbvie-86x64.jpg","210":"Abbvie-210x136.jpg","1920":"Abbvie.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/abbvie-completes-acquisition-of-immunogen/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/abbvie-completes-acquisition-of-immunogen/" class="post-url post-title"> AbbVie Completes Acquisition of ImmunoGen </a> </p> </div> </div > <div class="post-38561 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline" data-src="https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2018\/01\/","sizes":{"86":"Sanofi-86x64.jpg","210":"Sanofi-210x136.jpg","1280":"Sanofi.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/sanofi-to-acquire-inhibrx-inc-adding-potential-best-in-class-rare-disease-asset-for-alpha-1-antitrypsin-deficiency-to-pipeline/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/sanofi-to-acquire-inhibrx-inc-adding-potential-best-in-class-rare-disease-asset-for-alpha-1-antitrypsin-deficiency-to-pipeline/" class="post-url post-title"> Sanofi to acquire Inhibrx, Inc., adding potential… </a> </p> </div> </div > <div class="post-38460 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation" data-src="https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2017\/08\/","sizes":{"86":"Daiichi-Pharma-86x64.jpg","210":"Daiichi-Pharma-210x136.jpg","600":"Daiichi-Pharma.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/esperion-and-daiichi-sankyo-europe-announce-125-million-amendment-to-their-collaboration-including-resolution-of-pending-litigation/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/esperion-and-daiichi-sankyo-europe-announce-125-million-amendment-to-their-collaboration-including-resolution-of-pending-litigation/" class="post-url post-title"> Esperion and Daiichi Sankyo Europe Announce $125 Million… </a> </p> </div> </div > <div class="post-38456 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Avistone Biotechnology Announces Closing of Series B Financing" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"86":"Finance-86x64.jpg","210":"Finance-210x136.jpg","500":"Finance.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/avistone-biotechnology-announces-closing-of-series-b-financing/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/avistone-biotechnology-announces-closing-of-series-b-financing/" class="post-url post-title"> Avistone Biotechnology Announces Closing of Series B… </a> </p> </div> </div > <div class="post-37751 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-3"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital" data-src="https://pharmajournalist.com/wp-content/uploads/2021/03/Finance-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2021\/03\/","sizes":{"86":"Finance-86x64.jpg","210":"Finance-210x136.jpg","500":"Finance.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/apollo-therapeutics-closes-226-5-million-series-c-financing-led-by-patient-square-capital/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/apollo-therapeutics-closes-226-5-million-series-c-financing-led-by-patient-square-capital/" class="post-url post-title"> Apollo Therapeutics Closes $226.5 Million Series C… </a> </p> </div> </div > </div> </div></div> </aside> </div> <div class="col-sm-3"> <aside id="sidebar-footer-4" class="sidebar" role="complementary" aria-label="Footer - Column 4 Sidebar" itemscope="itemscope" itemtype="http://schema.org/WPSideBar"> <div id="bs-thumbnail-listing-1-3" class=" h-ni w-t footer-widget footer-column-4 widget widget_bs-thumbnail-listing-1"><div class=" bs-listing bs-listing-listing-thumbnail-1 bs-listing-single-tab"> <p class="section-heading sh-t1 sh-s3 main-term-35"> <a href="https://www.pharmajournalist.com/category/press-releases/" class="main-link"> <span class="h-text main-term-35"> Press Releases </span> </a> </p> <div class="listing listing-thumbnail listing-tb-1 clearfix columns-1"> <div class="post-40680 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="The Tumour Models Summit Hits Sweden!" data-src="https://pharmajournalist.com/wp-content/uploads/2025/03/Tumour-Models-Nordics-Infographic-86x64.jpg" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2025\/03\/","sizes":{"86":"Tumour-Models-Nordics-Infographic-86x64.jpg","210":"Tumour-Models-Nordics-Infographic-210x136.jpg","800":"Tumour-Models-Nordics-Infographic.jpg"}}" class="img-holder" href="https://www.pharmajournalist.com/the-tumour-models-summit-hits-sweden/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/the-tumour-models-summit-hits-sweden/" class="post-url post-title"> The Tumour Models Summit Hits Sweden! </a> </p> </div> </div > <div class="post-40102 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="5th Genome Editing Therapeutics Summit is only 3 weeks away!" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/47290-4-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"47290-4-86x64.png","210":"47290-4-210x136.png","800":"47290-4.png"}}" class="img-holder" href="https://www.pharmajournalist.com/5th-genome-editing-therapeutics-summit-is-only-3-weeks-away/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/5th-genome-editing-therapeutics-summit-is-only-3-weeks-away/" class="post-url post-title"> 5th Genome Editing Therapeutics Summit is only 3 weeks… </a> </p> </div> </div > <div class="post-40062 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/11th-World-ADC-Awards-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"11th-World-ADC-Awards-86x64.png","210":"11th-World-ADC-Awards-210x136.png","500":"11th-World-ADC-Awards.png"}}" class="img-holder" href="https://www.pharmajournalist.com/celebrating-more-than-a-decade-of-excellence-at-the-world-adc-awards-winners-announcement/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/celebrating-more-than-a-decade-of-excellence-at-the-world-adc-awards-winners-announcement/" class="post-url post-title"> Celebrating More than a Decade of Excellence at the World… </a> </p> </div> </div > <div class="post-40023 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="Final Week to Save $350: Accelerate Your Gene Editing Program" data-src="https://pharmajournalist.com/wp-content/uploads/2024/11/47290-4-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/11\/","sizes":{"86":"47290-4-86x64.png","210":"47290-4-210x136.png","800":"47290-4.png"}}" class="img-holder" href="https://www.pharmajournalist.com/final-week-to-save-350-accelerate-your-gene-editing-program/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/final-week-to-save-350-accelerate-your-gene-editing-program/" class="post-url post-title"> Final Week to Save $350: Accelerate Your Gene Editing… </a> </p> </div> </div > <div class="post-40020 type-post format-standard has-post-thumbnail listing-item listing-item-thumbnail listing-item-tb-1 main-term-35"> <div class="item-inner clearfix"> <div class="featured featured-type-featured-image"> <a title="An Interview with Jeffrey Cehelsky, Intellia Therapeutics" data-src="https://pharmajournalist.com/wp-content/uploads/2024/09/48775-Pharma-J-Banner-86x64.png" data-bs-srcset="{"baseurl":"https:\/\/pharmajournalist.com\/wp-content\/uploads\/2024\/09\/","sizes":{"86":"48775-Pharma-J-Banner-86x64.png","210":"48775-Pharma-J-Banner-210x136.png","300":"48775-Pharma-J-Banner.png"}}" class="img-holder" href="https://www.pharmajournalist.com/an-interview-with-jeffrey-cehelsky-intellia-therapeutics/"></a> </div> <p class="title"> <a href="https://www.pharmajournalist.com/an-interview-with-jeffrey-cehelsky-intellia-therapeutics/" class="post-url post-title"> An Interview with Jeffrey Cehelsky, Intellia Therapeutics </a> </p> </div> </div > </div> </div></div> </aside> </div> </div> </div> </div> </div> <div class="copy-footer"> <div class="content-wrap"> <div class="container"> <div class="row"> <div class="col-lg-12"> <div id="menu-footer" class="menu footer-menu-wrapper" role="navigation" itemscope="itemscope" itemtype="http://schema.org/SiteNavigationElement"> <nav class="footer-menu-container"> <ul id="footer-navigation" class="footer-menu menu clearfix"> <li class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-461"><a href="http://www.pharmajournalist.com/about/">About</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-462"><a href="http://www.pharmajournalist.com/advertise/">Advertise</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-464"><a href="http://www.pharmajournalist.com/subscribe/">Subscribe</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-page better-anim-fade menu-item-463"><a href="http://www.pharmajournalist.com/contact/">Contact</a></li> </ul> </nav> </div> </div> </div> <div class="row footer-copy-row"> <div class="copy-1 col-lg-6 col-md-6 col-sm-6 col-xs-12"> © 2025 - Pharma Journalist. All Rights Reserved. </div> <div class="copy-2 col-lg-6 col-md-6 col-sm-6 col-xs-12"> Pharma Journalist is a product of <img src = "http://www.oilandgasdrill.com/wp-content/uploads/2017/10/rsz_kellen_media.png"> </div> </div> </div> </div> </div> </footer> </div> <span class="back-top"><i class="fa fa-arrow-up"></i></span> <script> ( function ( body ) { 'use strict'; body.className = body.className.replace( /\btribe-no-js\b/, 'tribe-js' ); } )( document.body ); </script> <script> /* <![CDATA[ */var tribe_l10n_datatables = {"aria":{"sort_ascending":": activate to sort column ascending","sort_descending":": activate to sort column descending"},"length_menu":"Show _MENU_ entries","empty_table":"No data available in table","info":"Showing _START_ to _END_ of _TOTAL_ entries","info_empty":"Showing 0 to 0 of 0 entries","info_filtered":"(filtered from _MAX_ total entries)","zero_records":"No matching records found","search":"Search:","all_selected_text":"All items on this page were selected. ","select_all_link":"Select all pages","clear_selection":"Clear Selection.","pagination":{"all":"All","next":"Next","previous":"Previous"},"select":{"rows":{"0":"","_":": Selected %d rows","1":": Selected 1 row"}},"datepicker":{"dayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"dayNamesShort":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"dayNamesMin":["S","M","T","W","T","F","S"],"monthNames":["January","February","March","April","May","June","July","August","September","October","November","December"],"monthNamesShort":["January","February","March","April","May","June","July","August","September","October","November","December"],"monthNamesMin":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"nextText":"Next","prevText":"Prev","currentText":"Today","closeText":"Done","today":"Today","clear":"Clear"}};/* ]]> */ </script><script type="text/html" id="wpb-modifications"> window.wpbCustomElement = 1; </script><script type="text/javascript" id="publisher-theme-pagination-js-extra"> /* <![CDATA[ */ var bs_pagination_loc = {"loading":"<div class=\"bs-loading\"><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><\/div>"}; /* ]]> */ </script> <script type="text/javascript" id="publisher-js-extra"> /* <![CDATA[ */ var publisher_theme_global_loc = {"page":{"boxed":"full-width"},"header":{"style":"style-2","boxed":"full-width"},"ajax_url":"https:\/\/pharmajournalist.com\/wp-admin\/admin-ajax.php","loading":"<div class=\"bs-loading\"><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><div><\/div><\/div>","translations":{"tabs_all":"All","tabs_more":"More","lightbox_expand":"Expand the image","lightbox_close":"Close"},"lightbox":{"not_classes":""},"main_menu":{"more_menu":"enable"},"top_menu":{"more_menu":"enable"},"skyscraper":{"sticky_gap":30,"sticky":true,"position":""},"share":{"more":true},"refresh_googletagads":"1","get_locale":"en-US","notification":{"subscribe_msg":"By clicking the subscribe button you will never miss the new articles!","subscribed_msg":"You're subscribed to notifications","subscribe_btn":"Subscribe","subscribed_btn":"Unsubscribe"}}; var publisher_theme_ajax_search_loc = {"ajax_url":"https:\/\/pharmajournalist.com\/wp-admin\/admin-ajax.php","previewMarkup":"<div class=\"ajax-search-results-wrapper ajax-search-no-product ajax-search-fullwidth\">\n\t<div class=\"ajax-search-results\">\n\t\t<div class=\"ajax-ajax-posts-list\">\n\t\t\t<div class=\"clean-title heading-typo\">\n\t\t\t\t<span>Posts<\/span>\n\t\t\t<\/div>\n\t\t\t<div class=\"posts-lists\" data-section-name=\"posts\"><\/div>\n\t\t<\/div>\n\t\t<div class=\"ajax-taxonomy-list\">\n\t\t\t<div class=\"ajax-categories-columns\">\n\t\t\t\t<div class=\"clean-title heading-typo\">\n\t\t\t\t\t<span>Categories<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"posts-lists\" data-section-name=\"categories\"><\/div>\n\t\t\t<\/div>\n\t\t\t<div class=\"ajax-tags-columns\">\n\t\t\t\t<div class=\"clean-title heading-typo\">\n\t\t\t\t\t<span>Tags<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"posts-lists\" data-section-name=\"tags\"><\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>","full_width":"1"}; /* ]]> */ </script> <div class="rh-cover noscroll " > <span class="rh-close"></span> <div class="rh-panel rh-pm"> <div class="rh-p-h"> <span class="user-login"> <span class="user-avatar user-avatar-icon"><i class="fa fa-user-circle"></i></span> Sign in </span> </div> <div class="rh-p-b"> <div class="rh-c-m clearfix"></div> <form role="search" method="get" class="search-form" action="http://www.pharmajournalist.com"> <input type="search" class="search-field" placeholder="Search..." value="" name="s" title="Search for:" autocomplete="off"> <input type="submit" class="search-submit" value=""> </form> </div> </div> <div class="rh-panel rh-p-u"> <div class="rh-p-h"> <span class="rh-back-menu"><i></i></span> </div> <div class="rh-p-b"> <div id="form_29098_" class="bs-shortcode bs-login-shortcode "> <div class="bs-login bs-type-login" style="display:none"> <div class="bs-login-panel bs-login-sign-panel bs-current-login-panel"> <form name="loginform" action="https://pharmajournalist.com/wp-login.php" method="post"> <div class="login-header"> <span class="login-icon fa fa-user-circle main-color"></span> <p>Welcome, Login to your account.</p> </div> <div class="login-field login-username"> <input type="text" name="log" id="form_29098_user_login" class="input" value="" size="20" placeholder="Username or Email..." required/> </div> <div class="login-field login-password"> <input type="password" name="pwd" id="form_29098_user_pass" class="input" value="" size="20" placeholder="Password..." required/> </div> <div class="login-field"> <a href="https://pharmajournalist.com/wp-login.php?action=lostpassword&redirect_to=http%3A%2F%2Fwww.pharmajournalist.com%2F" class="go-reset-panel">Forget password?</a> <span class="login-remember"> <input class="remember-checkbox" name="rememberme" type="checkbox" id="form_29098_rememberme" value="forever" /> <label class="remember-label">Remember me</label> </span> </div> <div class="login-field login-submit"> <input type="submit" name="wp-submit" class="button-primary login-btn" value="Log In"/> <input type="hidden" name="redirect_to" value="http://www.pharmajournalist.com/"/> </div> </form> </div> <div class="bs-login-panel bs-login-reset-panel"> <span class="go-login-panel"><i class="fa fa-angle-left"></i> Sign in</span> <div class="bs-login-reset-panel-inner"> <div class="login-header"> <span class="login-icon fa fa-support"></span> <p>Recover your password.</p> <p>A password will be e-mailed to you.</p> </div> <form name="lostpasswordform" id="form_29098_lostpasswordform" action="https://pharmajournalist.com/wp-login.php?action=lostpassword" method="post"> <div class="login-field reset-username"> <input type="text" name="user_login" class="input" value="" placeholder="Username or Email..." required/> </div> <div class="login-field reset-submit"> <input type="hidden" name="redirect_to" value=""/> <input type="submit" name="wp-submit" class="login-btn" value="Send My Password"/> </div> </form> </div> </div> </div> </div> </div> </div> </div> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/better-adsmanager/js/advertising.min.js?ver=1.21.0" id="better-advertising-js"></script> <script type="text/javascript" src="http://pharmajournalist.com/wp-content/plugins/js_composer/assets/js/dist/js_composer_front.min.js?ver=7.9" id="wpb_composer_front_js-js"></script> <script type="text/javascript" async="async" src="http://pharmajournalist.com/wp-content/bs-booster-cache/6b2d9a9fe48ae1c69aaa67fedbddc0aa.js?ver=6.7.2" id="bs-booster-js"></script> <script></script> <script> var npbh=function(t){"use strict";return{init:function(){0==npbh.ads_state()&&npbh.blocked_ads_fallback()},ads_state:function(){return void 0!==window.better_ads_adblock},blocked_ads_fallback:function(){var a=[];t(".npbh-container").each(function(){if("image"==t(this).data("type"))return 0;a.push({element_id:t(this).attr("id"),ad_id:t(this).data("adid")})}),a.length<1||jQuery.ajax({url:'https://pharmajournalist.com/wp-admin/admin-ajax.php',type:"POST",data:{action:"better_ads_manager_blocked_fallback",ads:a},success:function(a){var e=JSON.parse(a);t.each(e.ads,function(a,e){t("#"+e.element_id).html(e.code)})}})}}}(jQuery);jQuery(document).ready(function(){npbh.init()}); </script>  <div id="cookie-notice" role="dialog" class="cookie-notice-hidden cookie-revoke-hidden cn-position-top" aria-label="Cookie Notice" style="background-color: rgba(0,0,0,1);"><div class="cookie-notice-container" style="color: #fff"><span id="cn-notice-text" class="cn-text-container">We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.</span><span id="cn-notice-buttons" class="cn-buttons-container"><a href="#" id="cn-accept-cookie" data-cookie-set="accept" class="cn-set-cookie cn-button cn-button-custom button" aria-label="Ok">Ok</a><a href="http://www.pharmajournalist.com/cookie-policy/" target="_blank" id="cn-more-info" class="cn-more-info cn-button cn-button-custom button" aria-label="Learn More">Learn More</a></span><span id="cn-close-notice" data-cookie-set="accept" class="cn-close-icon" title="No"></span></div> </div>  </body> </html>

CINXE.COM

Pharma Journalist - Leading Magazine for Pharmaceutical Professionals